Deal Tracker · Years
Emerging-market pharma deals in 2026
193 pharma deals announced in 2026 across GCC, MENA, Latin America & Southeast Asia, tracked by EPT — licensing, distribution & localization. Most active: ADCAN Pharma, Mubadala Bio, SPIMACO & Arcera Life Sciences. Latest: Laboratorios Siegfried → Laboratorio Chile (M&A / Acquisition, 19 Nov 2026).
- EPT has tracked 193 emerging-market pharma deals in 2026.
- The most common structures are licensing (21%), distribution (19%) & partnerships (15%).
- The countries that appear most often are UAE (53), Saudi Arabia (48), United States (24) & Egypt (20).
- Values were disclosed for 34 of 193 deals, totalling $2.7bn; the largest is DKSH → NewBridge Pharmaceuticals ($390m, 19 Oct 2026).
- The most active companies: ADCAN Pharma (13), Mubadala Bio (8), SPIMACO (6) & Arcera Life Sciences (5).
- Laboratorios Siegfried → Laboratorio ChileM&A / Acquisition · Latin America · $18.1m · 19 Nov 2026
- Innogen Pharmaceuticals → Arcera Life SciencesLicensing · Global (LMICs) · Undisclosed · 19 Nov 2026
- Eva Pharma → Med RightPartnership / Collaboration · MENA · Undisclosed · 18 Nov 2026
- Celltrion → Brazilian federal governmentSupply / Manufacturing · Latin America · Undisclosed · 17 Nov 2026
- Gilead Sciences → Dr. Reddy's LaboratoriesLicensing · Global (LMICs) · Royalty-free · 16 Nov 2026
- Gilead Sciences → Ferozsons LaboratoriesLicensing · Global (LMICs) · Royalty-free · 16 Nov 2026
- Gilead Sciences → Eva PharmaLicensing · Global (LMICs) · Royalty-free · 16 Nov 2026
- Farmacias del Ahorro → Farmacias BenavidesM&A / Acquisition · Latin America · Undisclosed · 13 Nov 2026
- Emmaus Life Sciences → Al Wataniya AldawliyaDistribution · MENA · Undisclosed · 12 Nov 2026
- Santhera Pharmaceuticals → SteinCaresDistribution · Latin America · Undisclosed · 12 Nov 2026
- Emirates Drug Establishment → ViatrisPartnership / Collaboration · GCC · Undisclosed · 11 Nov 2026
- Viatris → ADCAN PharmaTechnology transfer / Localization · GCC · Undisclosed · 11 Nov 2026
- Hikma Ventures → Rem3dy HealthEquity / Investment · MENA · Undisclosed · 11 Nov 2026
- Bristol Myers Squibb → A.C.Camargo Cancer CenterPartnership / Collaboration · Latin America · Undisclosed · 9 Nov 2026
- AMA Medical Manufacturing → Barbados PharmaceuticalPartnership / Collaboration · Latin America · See terms · 9 Nov 2026
- Afreximbank → AMA Medical ManufacturingEquity / Investment · Latin America · Undisclosed · 9 Nov 2026
- Sandoz → BiolabDistribution · Latin America · Undisclosed · 9 Nov 2026
- Saudi Industrial Development Fund → Avalon PharmaEquity / Investment · GCC · $16m · 9 Nov 2026
- M42 → ADCAN PharmaPartnership / Collaboration · GCC · Undisclosed · 9 Nov 2026
- Oman Investment Authority → Oryx IsotopesJoint venture · GCC · $17m · 8 Nov 2026
- Alkem Laboratories → Vitals BiotechJoint venture · GCC · $2m · 8 Nov 2026
- Novo Nordisk → AbbottDistribution · Southeast Asia · Undisclosed · 5 Nov 2026
- Dawah Pharma → HoldiPharmaJoint venture · MENA · Undisclosed · 5 Nov 2026
- Bukwang Pharmaceutical → NASAQLicensing · GCC · $2.7m · 4 Nov 2026
- Korea Pharmbio → Ashro Drug StoreDistribution · GCC · Undisclosed · 3 Nov 2026
- Geropharm → Al Quds Medical ProductsTechnology transfer / Localization · MENA · Undisclosed · 3 Nov 2026
- Roche Pharmaceuticals UAE → Department of Health – Abu DhabiPartnership / Collaboration · GCC · Undisclosed · 2 Nov 2026
- Ennogen Healthcare → Aspen PharmacareM&A / Acquisition · Africa · $220m · 2 Nov 2026
- Aram Pharma → Salalah Free ZoneEquity / Investment · GCC · Undisclosed · 1 Nov 2026
- Al Badr Trading & Industry, Lamaa Pharma, Al Mansoor + 1 other → Khazaen Economic CityEquity / Investment · GCC · $52m · 1 Nov 2026
- Galenicum → Al Ittihad Drug StoreDistribution · GCC · Undisclosed · 31 Oct 2026
- Rem3dy Health → Hikma PharmaceuticalsDistribution · GCC · Undisclosed · 29 Oct 2026
- Novartis → Department of Health – Abu DhabiPartnership / Collaboration · GCC · Undisclosed · 28 Oct 2026
- DKSH → RocheM&A / Acquisition · Global (LMICs) · Undisclosed · 28 Oct 2026
- Casablanca Stock Exchange IPO → LaprophanEquity / Investment · MENA · $225m · 28 Oct 2026
- Sothema → Ramo PharmM&A / Acquisition · MENA · $6m · 28 Oct 2026
- Uruguay stock exchanges IPO → FarmashopEquity / Investment · Latin America · Undisclosed · 27 Oct 2026
- Kimia Farma → Open to partnersSupply / Manufacturing · Southeast Asia · Undisclosed · 27 Oct 2026
- Adalvo → SinoPepSupply / Manufacturing · Global (LMICs) · Undisclosed · 27 Oct 2026
- Institut Teknologi Bandung → IndofarmaPartnership / Collaboration · Southeast Asia · Undisclosed · 27 Oct 2026
- Janssen Sciences Ireland → BioconLicensing · Global (LMICs) · Undisclosed · 26 Oct 2026
- Roche → Iraq Ministry of HealthPartnership / Collaboration · MENA · Undisclosed · 26 Oct 2026
- Eva Pharma → United PharmaciesDistribution · GCC · Undisclosed · 26 Oct 2026
- Walvax → Vaccine and Biotechnology CityTechnology transfer / Localization · MENA · Undisclosed · 26 Oct 2026
- Sanofi → Nobel AFFTechnology transfer / Localization · CIS & Central Asia · Undisclosed · 26 Oct 2026
- Rameda → Art PharmaM&A / Acquisition · MENA · $20m · 26 Oct 2026
- Autotelic Bio → MenariniLicensing · MENA · Undisclosed · 26 Oct 2026
- Pinnacology Research & Development → Prognica LabsPartnership / Collaboration · GCC · Undisclosed · 25 Oct 2026
- Orchid Pharma → Laboratorio LibraLicensing · Latin America · $80m · 24 Oct 2026
- Algerian laboratories → Tunisian, Mauritanian and Jordanian laboratoriesPartnership / Collaboration · MENA · Undisclosed · 24 Oct 2026
- Korea United Pharm → Dai Nam Ha NoiDistribution · Southeast Asia · $0.8m · 23 Oct 2026
- Korea United Pharm → Qualimed PharmaDistribution · Southeast Asia · $2.5m · 23 Oct 2026
- HarmeeCare Pharmaceuticals → Kilitch Estro BiotechM&A / Acquisition · Africa · $14m · 23 Oct 2026
- QOL Medical → Qurqas Pharmaceutical WarehouseDistribution · MENA · Undisclosed · 22 Oct 2026
- Mubadala Bio → Arabian EthicalsDistribution · GCC · 22 Oct 2026
- Miltenyi Biomedicine → Abu Dhabi Stem Cells CenterPartnership / Collaboration · GCC · 22 Oct 2026
- Abbott → Mubadala BioTechnology transfer / Localization · GCC · 22 Oct 2026
- Yichang HEC Changjiang Pharmaceutical → Pharmaniaga LifeScienceTechnology transfer / Localization · Southeast Asia · 22 Oct 2026
- Samsung Bioepis → BionovisTechnology transfer / Localization · Latin America · Undisclosed · 21 Oct 2026
- Samsung Bioepis → BahiafarmaTechnology transfer / Localization · Latin America · Undisclosed · 21 Oct 2026
- Enzymatica → MedonyXDistribution · MENA · Undisclosed · 21 Oct 2026
- Department of Health – Abu Dhabi / Cleveland Clinic Abu Dhabi → AstraZenecaGCC · See terms · 21 Oct 2026
- Department of Health – Abu Dhabi → WHOOPGCC · 21 Oct 2026
- Department of Health – Abu Dhabi → Isomorphic LabsGCC · 21 Oct 2026
- Mubadala Bio → Modern PharmaceuticalDistribution · GCC · 21 Oct 2026
- Laprophan → PolymedicM&A / Acquisition · Africa · 21 Oct 2026
- Mubadala Bio → Jamjoom PharmaDistribution · GCC · 21 Oct 2026
- Marcyrl Pharmaceutical Industries → Mubadala BioTechnology transfer / Localization · GCC · 21 Oct 2026
- RMBV → ATCO PharmaEquity / Investment · MENA · Undisclosed · 21 Oct 2026
- MS Pharma → ADCAN PharmaTechnology transfer / Localization · GCC · 20 Oct 2026
- Sanofi → Mubadala BioDistribution · GCC · 20 Oct 2026
- EastPharma → SanofiM&A / Acquisition · Africa · 20 Oct 2026
- Eli Lilly → Mubadala BioSupply / Manufacturing · GCC · Undisclosed · 20 Oct 2026
- DKSH → NewBridge PharmaceuticalsM&A / Acquisition · MENA · $390m · 19 Oct 2026
- Macleods Pharmaceuticals → New Country HealthcareDistribution · GCC · 17 Oct 2026
- Cinfa → LifePharmaTechnology transfer / Localization · GCC · 16 Oct 2026
- Enimmune → Duopharma BiotechDistribution · Southeast Asia · Undisclosed · 15 Oct 2026
- ADCAN Pharma → Zulekha Medical StoreDistribution · GCC · Undisclosed · 15 Oct 2026
- Yangtze River Pharmaceutical → Pharma InvestTechnology transfer / Localization · Africa · 15 Oct 2026
- Gen İlaç → SK-PharmacySupply / Manufacturing · CIS & Central Asia · $0.8m · 14 Oct 2026
- Nxera Pharma → Synmosa BiopharmaLicensing · Southeast Asia · Undisclosed · 14 Oct 2026
- Avenzo Pharma → Khazaen Economic CityEquity / Investment · GCC · Undisclosed · 14 Oct 2026
- Ocugen → Roots PharmaceuticalLicensing · MENA · $259m · 14 Oct 2026
- Inventia Healthcare → ADCAN PharmaLicensing · GCC · 14 Oct 2026
- JCR Pharmaceuticals → Taiba HealthcareDistribution · GCC · 14 Oct 2026
- Sandoz → Tabuk PharmaceuticalsTechnology transfer / Localization · GCC · Undisclosed · 13 Oct 2026
- Incyte → Gen İlaçDistribution · Türkiye · Undisclosed · 12 Oct 2026
- Philex Pharmaceuticals → BiocareTechnology transfer / Localization · Africa · 11 Oct 2026
- Algeria — Ministry of Pharmaceutical Industry / ANPP → Kuwait — Ministry of HealthPartnership / Collaboration · MENA · 11 Oct 2026
- Lotus Pharmaceutical → ADCAN PharmaLicensing · MENA · 9 Oct 2026
- Genepharm → ADCAN PharmaLicensing · GCC · 9 Oct 2026
- Alvion Pharmaceuticals → ADCAN PharmaLicensing · GCC · 8 Oct 2026
- Elpen → ADCAN PharmaLicensing · GCC · 8 Oct 2026
- ADCAN Pharma → Pharma ResourcesPartnership / Collaboration · GCC · 8 Oct 2026
- Sana Pharma → National Pharmaceutical IndustriesPartnership / Collaboration · GCC · 8 Oct 2026
- Dhofar Pharmaceutical Industries → Philex PharmaceuticalsPartnership / Collaboration · GCC · 8 Oct 2026
- Dhofar Pharmaceutical Industries → Hydrogen Oncology PharmaceuticalsTechnology transfer / Localization · MENA · 8 Oct 2026
- OneSource Specialty Pharma → Avalon PharmaLicensing · MENA · Undisclosed · 8 Oct 2026
- Accord Healthcare → CenturionLicensing · Türkiye · Undisclosed · 8 Oct 2026
- Elpen → ADCAN PharmaLicensing · GCC · 7 Oct 2026
- FM6I → MARBIOM&A / Acquisition · MENA · Undisclosed · 6 Oct 2026
- Aurisco Pharmaceutical → Avalon PharmaPartnership / Collaboration · MENA · Undisclosed · 6 Oct 2026
- Gen İlaç → Azerbaijan Business Development FundJoint venture · CIS & Central Asia · $67m · 5 Oct 2026
- Dar Al Dawa → MicroSynergy PharmaSupply / Manufacturing · GCC · Undisclosed · 30 Sept 2026
- Kyowa Kirin → Knight TherapeuticsDistribution · Latin America · Undisclosed · 29 Sept 2026
- Medicines Patent Pool → 11 generic manufacturersLicensing · Global (LMICs) · Undisclosed · 29 Sept 2026
- Undisclosed Chinese manufacturer → Newbury PharmaceuticalsLicensing · MENA · Undisclosed · 28 Sept 2026
- Dr. Reddy's Laboratories → Hikma PharmaceuticalsLicensing · MENA · 28 Sept 2026
- Cordex Biologics → Farma MondoDistribution · GCC · 25 Sept 2026
- OMEZA → Hikma PharmaceuticalsLicensing · MENA · Undisclosed · 21 Sept 2026
- Global Pharma → PrinceFarmaDistribution · Africa · Undisclosed · 17 Sept 2026
- Eva Pharma → CCL PharmaceuticalsPartnership / Collaboration · Southeast Asia · Undisclosed · 17 Sept 2026
- Local Content and Government Procurement Authority → SPIMACOTechnology transfer / Localization · GCC · Undisclosed · 16 Sept 2026
- Chiesi → Abdi İbrahimDistribution · Türkiye · Undisclosed · 16 Sept 2026
- Shilpa Biologicals → SPIMACOLicensing · MENA · Undisclosed · 15 Sept 2026
- KyungDong Pharmaceutical → Kazakhstan Ministry of HealthPartnership / Collaboration · CIS & Central Asia · Undisclosed · 14 Sept 2026
- Nordic Pharma → Jamjoom PharmaLicensing · MENA · Undisclosed · 14 Sept 2026
- UNIMED Laboratories → Al-Qawsan Scientific BureauDistribution · MENA · Undisclosed · 14 Sept 2026
- Roche → Groupe SaidalTechnology transfer / Localization · Africa · Undisclosed · 10 Sept 2026
- Pharmacare Premium → Arabian OasisPartnership / Collaboration · GCC · Undisclosed · 3 Sept 2026
- Keymed Biosciences → AeiraLicensing · Southeast Asia · Undisclosed · 2 Sept 2026
- Pinnacle Life Science → ADCAN PharmaLicensing · GCC · Undisclosed · 2 Sept 2026
- CFAO Healthcare → OPHAMM&A / Acquisition · Africa · Undisclosed · 31 Aug 2026
- AstraZeneca → KAIMRCPartnership / Collaboration · GCC · 29 Aug 2026
- CEPI → MinapharmPartnership / Collaboration · Africa · $16.5m · 27 Aug 2026
- Rhei Life → Atheer PharmaDistribution · GCC · Undisclosed · 21 Aug 2026
- Cosmos Health → Innova HealthcareDistribution · GCC · Undisclosed · 20 Aug 2026
- Bio-Thera Solutions → Avalon PharmaLicensing · MENA · Undisclosed · 16 Aug 2026
- Alfasigma → Nordic PharmaM&A / Acquisition · Global ex-US · See terms · 9 Aug 2026
- MSD → 7 generic manufacturersLicensing · Global (LMICs) · See terms · 5 Aug 2026
- Gypto Pharma → BachaDistribution · Africa · Undisclosed · 4 Aug 2026
- IMPACT Therapeutics → PharmanoviaLicensing · Global (LMICs) · See terms · 31 Jul 2026
- SPIMACO → Cigalah Drug StoreDistribution · GCC · Undisclosed · 30 Jul 2026
- SPIMACO → Cigalah Gulf MedicalDistribution · GCC · Undisclosed · 30 Jul 2026
- African Development Bank → BiovacEquity / Investment · Africa · $15m · 30 Jul 2026
- Mabwell Bioscience → SaudiVaxLicensing · GCC · Undisclosed · 29 Jul 2026
- Idorsia → Jamjoom PharmaLicensing · MENA · See terms · 27 Jul 2026
- Sino Biopharmaceutical → Tempo ScanJoint venture · Southeast Asia · Undisclosed · 24 Jul 2026
- Lifera → Jamjoom PharmaJoint venture · GCC · See terms · 23 Jul 2026
- Servier → Pharma CapitalM&A / Acquisition · MENA · Undisclosed · 23 Jul 2026
- Itqan Pharmaceuticals → Address HealthcareDistribution · GCC · Undisclosed · 21 Jul 2026
- JCR Pharmaceuticals → Taiba HealthcareDistribution · MENA · Undisclosed · 21 Jul 2026
- Galenicum → Dar Al DawaLicensing · MENA · Undisclosed · 14 Jul 2026
- Northwest Biotherapeutics → SPIMACOPartnership / Collaboration · MENA · Undisclosed · 12 Jul 2026
- Bausch Health → AUG PharmaM&A / Acquisition · GCC · Undisclosed · 12 Jul 2026
- Natco Pharma → Adcock IngramEquity / Investment · Africa · $260m · 8 Jul 2026
- Biocon → Duopharma BiotechSupply / Manufacturing · Southeast Asia · See terms · 2 Jul 2026
- Dongkook Pharmaceutical → Faes FarmaLicensing · Latin America · See terms · 1 Jul 2026
- Adalvo → Doctors PharmaceuticalLicensing · MENA · Undisclosed · 1 Jul 2026
- Cadila Pharmaceuticals → WellestaJoint venture · Southeast Asia · Undisclosed · 30 Jun 2026
- Novo Nordisk Algérie → Groupe SaidalTechnology transfer / Localization · MENA · Undisclosed · 30 Jun 2026
- Daewoong Pharmaceutical → Arcera Life SciencesLicensing · MENA · $94m · 29 Jun 2026
- Biosidus → Mubadala BioLicensing · GCC · Undisclosed · 24 Jun 2026
- Genetix Biotherapeutics → SPIMACOLicensing · MENA · Undisclosed · 23 Jun 2026
- CEL-SCI → Saudi AmaroxDistribution · MENA · Undisclosed · 22 Jun 2026
- Laprophan → RivopharmM&A / Acquisition · MENA · Undisclosed · 17 Jun 2026
- Türk İlaç ve Serum → PharexpoDistribution · Türkiye · Undisclosed · 16 Jun 2026
- Egyptian Ministry of Health and Population / Egyptian Drug Authority → International partnersTechnology transfer / Localization · MENA · Undisclosed · 16 Jun 2026
- Glaxo Saudi Arabia → AJA PharmaPartnership / Collaboration · GCC · Undisclosed · 15 Jun 2026
- Menarini → ADCAN PharmaTechnology transfer / Localization · GCC · Undisclosed · 12 Jun 2026
- LVP Pharma → RamedaEquity / Investment · MENA · EGP 847m for 8.3% · 10 Jun 2026
- Boehringer Ingelheim → Groupe SaidalTechnology transfer / Localization · MENA · Undisclosed · 8 Jun 2026
- Novo Nordisk → Emirates Drug EstablishmentPartnership / Collaboration · GCC · Undisclosed · 8 Jun 2026
- M42 → Arcera Life SciencesPartnership / Collaboration · GCC · Undisclosed · 3 Jun 2026
- Kazakhstan Ministry of Health → Steppe PharmaceuticalsTechnology transfer / Localization · CIS & Central Asia · $71m · 26 May 2026
- Polpharma Biologics → TuteurLicensing · Latin America · Undisclosed · 22 May 2026
- Hanmi Pharmaceutical → OrganonDistribution · Southeast Asia · $34m · 21 May 2026
- Biocare Biotech → Dorcas LaboratoiresTechnology transfer / Localization · MENA · Undisclosed · 20 May 2026
- Kazakhstan Ministry of Health → Karaganda Pharmaceutical ComplexTechnology transfer / Localization · CIS & Central Asia · $89.7m · 15 May 2026
- AbbVie & Abbott → Groupe SaidalPartnership / Collaboration · MENA · Undisclosed · 13 May 2026
- Livzon → ImexpharmM&A / Acquisition · Southeast Asia · $221m · 11 May 2026
- Emirates Drug Establishment → Arcera Life SciencesPartnership / Collaboration · GCC · Undisclosed · 5 May 2026
- LifePharma → BurjeelJoint venture · GCC · $27.2m · 3 May 2026
- Fosun Pharma → Arcera Life SciencesPartnership / Collaboration · GCC · Undisclosed · 28 Apr 2026
- Pfizer → Jamjoom PharmaM&A / Acquisition · MENA · Undisclosed · 27 Apr 2026
- Jerusalem Pharmaceuticals → Saudi investorsJoint venture · GCC · Undisclosed · 15 Apr 2026
- Hybio Pharmaceutical → MCG PharmaLicensing · Türkiye · Undisclosed · 10 Apr 2026
- Lotus Pharmaceutical → Sandoz PhilippinesM&A / Acquisition · Southeast Asia · Undisclosed · 3 Apr 2026
- Sandoz → Strides PharmaM&A / Acquisition · Africa · $12m · 17 Mar 2026
- EBRD → Samarkand England Eco-Medical & Bayan MedicalEquity / Investment · CIS & Central Asia · Up to €20 million · 26 Feb 2026
- Kazakhstan Ministry of Health → Polpharma SantoEquity / Investment · CIS & Central Asia · $79.5m · 23 Feb 2026
- Misk Pharmaceutical Industries → UNIMED LaboratoriesDistribution · GCC · Undisclosed · 12 Feb 2026
- Moderna → Government of Mexico / BIRMEXSupply / Manufacturing · Latin America · Undisclosed · 10 Feb 2026
- Bio-Thera Solutions → Avalon PharmaLicensing · MENA · Undisclosed · 3 Feb 2026
- Chemo & Olpha → CCL PharmaceuticalsSupply / Manufacturing · GCC · Undisclosed · 28 Jan 2026
- Abdi İbrahim → Abdi Ibrahim Global PharmTechnology transfer / Localization · CIS & Central Asia · $83m · 22 Jan 2026
- World Medicine & Rompharm → MSP-ROMPHARMTechnology transfer / Localization · CIS & Central Asia · $78m · 22 Jan 2026
- Sinopharm, Sinovac & Kangtai Biological Technology → AltINFARMTechnology transfer / Localization · CIS & Central Asia · $125m · 22 Jan 2026
- Nobel İlaç → Nobel Almaty Pharmaceutical FactoryTechnology transfer / Localization · CIS & Central Asia · $84m · 22 Jan 2026
- Galenicum → LupinLicensing · Global (LMICs) · Undisclosed · 21 Jan 2026
- Gulf Pharmaceutical Industries and Medical Devices → Khazaen Economic CityEquity / Investment · GCC · $39m · 14 Jan 2026
- Kazakhstan Ministry of Health → Khan Tengri BiopharmaEquity / Investment · CIS & Central Asia · See terms · 1 Jan 2026
- Minhai Biotechnology → VACSERATechnology transfer / Localization · Africa · 1 Jan 2026
Most active companies
ADCAN Pharma (13) · Mubadala Bio (8) · SPIMACO (6) · Arcera Life Sciences (5) · Avalon Pharma (5) · Jamjoom Pharma (5)
Countries involved
UAE (53) · Saudi Arabia (48) · United States (24) · Egypt (20) · China (18) · Switzerland (17)
Largest disclosed deals
- DKSH → NewBridge Pharmaceuticals · $390m · M&A / Acquisition · 19 Oct 2026
- Natco Pharma → Adcock Ingram · $260m · Equity / Investment · 8 Jul 2026
- Ocugen → Roots Pharmaceutical · $259m · Licensing · 14 Oct 2026
Questions
- How many emerging-market pharma deals in 2026 has EPT tracked?
- 193 as of 19 Nov 2026. The most recent is Laboratorios Siegfried → Laboratorio Chile (M&A / Acquisition, 19 Nov 2026).
- What types of emerging-market pharma deals in 2026 are most common?
- Licensing: 41 (21%); Distribution: 37 (19%); Partnership / Collaboration: 29 (15%); Technology transfer / Localization: 29 (15%).
- Which companies are most active in emerging-market pharma deals in 2026?
- ADCAN Pharma (13 deals), Mubadala Bio (8 deals), SPIMACO (6 deals), Arcera Life Sciences (5 deals), Avalon Pharma (5 deals), Jamjoom Pharma (5 deals).
- What is the largest disclosed emerging-market pharma deal in 2026?
- DKSH → NewBridge Pharmaceuticals: $390m (M&A / Acquisition, 19 Oct 2026); Natco Pharma → Adcock Ingram: $260m (Equity / Investment, 8 Jul 2026); Ocugen → Roots Pharmaceutical: $259m (Licensing, 14 Oct 2026). Values are as announced by the parties.
- Which countries appear most in emerging-market pharma deals in 2026?
- UAE (53), Saudi Arabia (48), United States (24), Egypt (20), China (18), Switzerland (17) — counting where the parties are based and the markets the deals cover.
Browse deals
By region
GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)
By country
Saudi Arabia (69) · UAE (61) · China (31) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Algeria (12) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)
By deal type
Licensing (56) · Distribution (41) · Technology transfer / Localization (39) · Partnership / Collaboration (35) · M&A / Acquisition (21) · Equity / Investment (18) · Joint venture (11) · Supply / Manufacturing (10)
Popular searches
MENA pharma licensing deals (25) · Saudi Arabia pharma licensing deals (24) · GCC pharma distribution deals (21) · GCC pharma partnerships (19) · China pharma licensing deals (17) · UAE pharma distribution deals (17) · GCC pharma localization & tech-transfer deals (15) · Saudi Arabia pharma distribution deals (14) · UAE pharma partnerships (13) · UAE pharma licensing deals (12) · Global (LMICs) pharma licensing deals (11) · India pharma licensing deals (11) · GCC pharma licensing deals (10) · MENA pharma partnerships (10) · Saudi Arabia pharma localization & tech-transfer deals (10) · MENA pharma localization & tech-transfer deals (9) · United States pharma licensing deals (9) · Egypt pharma localization & tech-transfer deals (8) · Saudi Arabia pharma partnerships (8) · CIS & Central Asia pharma localization & tech-transfer deals (7) · Kazakhstan pharma localization & tech-transfer deals (7) · MENA pharma distribution deals (7) · MENA pharma M&A deals (7) · United States pharma distribution deals (7)
By company
ADCAN Pharma (13) · Mubadala Bio (8) · Jamjoom Pharma (7) · SPIMACO (7) · Arcera Life Sciences (6) · Hikma Pharmaceuticals (6) · Bio-Thera Solutions (6) · Avalon Pharma (5) · Tabuk Pharmaceuticals (5) · Local Content and Government Procurement Authority (5) · Kazakhstan Ministry of Health (5) · Eva Pharma (4) · Sandoz (4) · Department of Health – Abu Dhabi (4) · Biocon (4) · Groupe Saidal (4) · Gilead Sciences (3) · Dr. Reddy's Laboratories (3) · Emirates Drug Establishment (3) · Novo Nordisk (3) · Khazaen Economic City (3) · Galenicum (3) · Roche (3) · Laprophan (3) · Sanofi (3) · Gen İlaç (3) · Taiba Healthcare (3) · Dar Al Dawa (3) · Lifera (3) · Celltrion (2) · Viatris (2) · Rem3dy Health (2) · AMA Medical Manufacturing (2) · Afreximbank (2) · M42 (2) · Abbott (2) · DKSH (2) · Adalvo (2) · Rameda (2) · Menarini (2) · Korea United Pharm (2) · Samsung Bioepis (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · Duopharma Biotech (2) · JCR Pharmaceuticals (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · Accord Healthcare (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · UNIMED Laboratories (2) · Minapharm (2) · SaudiVax (2) · Faes Farma (2) · AJA Pharma (2) · VACSERA (2) · Bayer (2) · Shanghai Henlius Biotech (2) · Julphar (2)
By therapeutic area
Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)